BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zorzopulos J, Opal SM, Hernando-Insúa A, Rodriguez JM, Elías F, Fló J, López RA, Chasseing NA, Lux-Lantos VA, Coronel MF, Franco R, Montaner AD, Horn DL. Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapy. World J Stem Cells 2017; 9(3): 45-67 [PMID: 28396715 DOI: 10.4252/wjsc.v9.i3.45] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Maeda M, Kojima T, Song Y, Takayama S. DNA-Based Biomaterials for Immunoengineering. Adv Healthc Mater 2019;8:e1801243. [PMID: 30516349 DOI: 10.1002/adhm.201801243] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
2 Leiguarda C, Coronel MF, Montaner AD, Villar MJ, Brumovsky PR. Long-lasting ameliorating effects of the oligodeoxynucleotide IMT504 on mechanical allodynia and hindpaw edema in rats with chronic hindpaw inflammation. Neurosci Lett 2018;666:17-23. [PMID: 29248616 DOI: 10.1016/j.neulet.2017.12.032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
3 Bianchi S, Martínez Allo VC, Massimino M, Lavignolle Heguy MDR, Borzone FR, Gomez Bustillo S, Chasseing NA, Libertun C, Montaner AD, Rabinovich GA, Toscano MA, Lux-Lantos VA, Bianchi MS. Oligonucleotide IMT504 Improves Glucose Metabolism and Controls Immune Cell Mediators in Female Diabetic NOD Mice. Nucleic Acid Ther 2021;31:155-71. [PMID: 33347786 DOI: 10.1089/nat.2020.0901] [Reference Citation Analysis]
4 Ju C, Liu R, Zhang Y, Zhang F, Sun J, Lv XB, Zhang Z. Exosomes May Be the Potential New Direction of Research in Osteoarthritis Management. Biomed Res Int 2019;2019:7695768. [PMID: 31781642 DOI: 10.1155/2019/7695768] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]